Fig. 1From: Comprehensive screening of target molecules by next-generation sequencing in patients with malignant solid tumors: guiding entry into phase I clinical trialsRegistered and analyzed tumors in the TOPICS-1 study. The diagnoses of patients who underwent genomic testing. Each diagnosis included a variety of different histologic subtypesBack to article page